Dabrafenib Mesylate (GSK-2118436) | A3347-100

Dabrafenib Mesylate (GSK-2118436) | A3347-100 | Gentaur US, UK & Europe Disrtribition

Purity: 0.9978

Short Sumary: Inhibitor of BRAF (V600) mutants

Category: MAPK Signaling|Raf

Synonyms: GSK-2118436 Mesylate;GSK2118436 Mesylate;GSK 2118436 Mesylate;GSK 2118436B,Tafinlar,

Formula: C24H24F3N5O5S3 GSK-2118436 Mesylate;GSK2118436 Mesylate;GSK 2118436 Mesylate;GSK 2118436B,Tafinlar,

Molecular Weight: 615.67

Chemical Name: N-[3-[5- (2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid

CAS: 1195768-06-9

Solubility: ≥30.75 mg/mL in DMSO; insoluble in H2O; ≥2.74 mg/mL in EtOH with gentle warming and ultrasonic

Storage: Store at -20°C

Shipping Condition: Blue Ice

Physical Appearance: A solid